JENNIFER MOONEYHAM: Open Payments
NPI 1467164293 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 32 payments from 13 companies in 2025. Trend: 2023 $885 · 2024 $1,189 · 2025 $767
Food & beverage: $652Education: $115
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $214 |
| UCB, Inc. | 7 | $148 |
| GENZYME CORPORATION | 3 | $114 |
| ABBVIE INC. | 2 | $60 |
| Lilly USA, LLC | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, TALTZ, ILUMYA, Cabtreo, COSENTYX.
Industry payments across SC — which companies pay providers there.
